|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-9-19
|
|
pubmed:abstractText |
Since the combination of cisplatin and docetaxel have demonstrated activity in squamous cell carcinomas of the lung and oesophagus before, promising results in recurrent metastatic head and neck cancer were expected.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0030-2414
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 S. Karger AG, Basel
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
145-50
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:12239449-Adult,
pubmed-meshheading:12239449-Aged,
pubmed-meshheading:12239449-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12239449-Carcinoma, Squamous Cell,
pubmed-meshheading:12239449-Cisplatin,
pubmed-meshheading:12239449-Combined Modality Therapy,
pubmed-meshheading:12239449-Disease-Free Survival,
pubmed-meshheading:12239449-Head and Neck Neoplasms,
pubmed-meshheading:12239449-Humans,
pubmed-meshheading:12239449-Middle Aged,
pubmed-meshheading:12239449-Neoplasm Metastasis,
pubmed-meshheading:12239449-Paclitaxel,
pubmed-meshheading:12239449-Palliative Care,
pubmed-meshheading:12239449-Recurrence,
pubmed-meshheading:12239449-Survival Rate,
pubmed-meshheading:12239449-Taxoids,
pubmed-meshheading:12239449-Time Factors
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
|
|
pubmed:affiliation |
Department of Internal Medicine I, Division of Oncology, University of Vienna, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
